Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Hikma Delivers On Authorized Xyrem In US

Also Strikes Deal With Junshi For Toripalimab In MENA Region

Jan 03 2023

• By David Wallace

Rocket Launch 2023 — Hikma has kicked off the year with a long-awaited launch • Source: Shutterstock

Related Content

Hikma Expectations Stabilize – But Generics Still Set To Take A Hit

Nov 03 2022

Hikma Will Push Harder To Make M&A Happen

Aug 10 2022

Hikma Eyes Return To Growth After Further Cutting Generics Forecasts

Aug 04 2022

Related Companies

Hikma Pharmaceuticals plc

Additional Topics

United States Middle East and Africa Launches Generic Drugs Deals BioPharmaceutical

More from Products

More from Generics Bulletin

Twitter feed RSS feed RSS feed

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.